Immuneering
IMRX
IMRX
52 hedge funds and large institutions have $119M invested in Immuneering in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
17
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Morgan Stanley
New York
|
$825K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$7.89M |
3 |
3
Barclays
London,
United Kingdom
|
$257K |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$179K |
5 |
5
State Street
Boston,
Massachusetts
|
$2.75M |